Diabetes Mellitus: Type 1 vs Type 2
40 Questions
3 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What percentage of patients may develop type 2 diabetes within 10 to 15 years after subsiding?

  • 20%
  • 40%
  • 30% (correct)
  • 50%
  • What is the HbA1C goal of treatment for diabetic patients?

  • Less than 9%
  • Less than 6.5%
  • Less than 8%
  • Less than 7% (correct)
  • What is the fasting blood glucose goal for diabetic patients?

  • 90 to 140 mg/dL
  • 80 to 130 mg/dL (correct)
  • 100 to 150 mg/dL
  • 70 to 100 mg/dL
  • What is the duration of action for rapid-acting insulin aspart?

    <p>3 to 5 hours</p> Signup and view all the answers

    What is the peak of action for inhaled insulin Afrezza?

    <p>12 to 15 minutes</p> Signup and view all the answers

    What is the duration of action for short-acting insulin regular?

    <p>6 to 10 hours</p> Signup and view all the answers

    What is the duration of action for intermediate-acting insulin isophane suspension?

    <p>10 to 18 hours</p> Signup and view all the answers

    What is the characteristic of insulin glargine (Lantus)?

    <p>Constant level of insulin in the body</p> Signup and view all the answers

    What is the primary cause of Type 1 Diabetes Mellitus?

    <p>Lack of insulin production or production of defective insulin</p> Signup and view all the answers

    Which of the following is a characteristic of Diabetic Ketoacidosis (DKA)?

    <p>Ketones in the serum, acidosis, and dehydration</p> Signup and view all the answers

    What is the typical percentage of patients with newly diagnosed Type 1 Diabetes Mellitus who present with Diabetic Ketoacidosis (DKA)?

    <p>25% to 30%</p> Signup and view all the answers

    Which of the following comorbid conditions is commonly associated with Type 2 Diabetes Mellitus?

    <p>Microalbuminemia and thrombotic events</p> Signup and view all the answers

    What is the term used to describe the collective comorbidities associated with Type 2 Diabetes Mellitus?

    <p>All of the above</p> Signup and view all the answers

    What is the primary concern in Gestational Diabetes?

    <p>Preventing birth defects</p> Signup and view all the answers

    What is the hallmark of Hyperosmolar Hyperglycemic Syndrome (HHS)?

    <p>Hyperglycemia, hyperosmolarity, and dehydration without significant ketoacidosis</p> Signup and view all the answers

    What is the common long-term complication of both Type 1 and Type 2 Diabetes Mellitus that affects the capillaries?

    <p>Microvascular disease</p> Signup and view all the answers

    Which of the following situations would increase concerns for a patient with DM?

    <p>The patient is under stress</p> Signup and view all the answers

    What is essential for thorough patient education regarding DM?

    <p>Disease process, diet and exercise recommendations, self-administration of insulin or oral drugs, and potential complications</p> Signup and view all the answers

    When administrating insulin, what should be checked before giving the insulin?

    <p>Blood glucose level before giving insulin</p> Signup and view all the answers

    When drawing up two types of insulin in one syringe, what should be done?

    <p>Always withdraw the regular or rapid-acting insulin first</p> Signup and view all the answers

    Why should metformin be discontinued if the patient is to undergo studies with contrast dye?

    <p>Because of possible renal effects</p> Signup and view all the answers

    What should be administered to a conscious patient with hypoglycemia?

    <p>Oral form of glucose</p> Signup and view all the answers

    What should be monitored to assess therapeutic response to insulin?

    <p>Decrease in blood glucose levels to the level prescribed by physician</p> Signup and view all the answers

    What is used to monitor long-term compliance with diet and drug therapy?

    <p>HbA1C</p> Signup and view all the answers

    What is the mechanism of action of GLP-1 injectable medications in patients with type 2 diabetes?

    <p>Enhance glucose-dependent insulin secretion, suppress elevated glucagon secretion</p> Signup and view all the answers

    What is the primary adverse effect of SGLT2 inhibitors that led to a 2018 FDA warning?

    <p>Necrotizing fasciitis of the perineum (Fournier's gangrene)</p> Signup and view all the answers

    What is the primary indication for GLP-1 injectable medications in patients with type 2 diabetes?

    <p>Indicated for patients with type 2 diabetes who have not been able to achieve blood glucose control with metformin, a sulfonylurea and/or a glitazone</p> Signup and view all the answers

    What is the primary action of SGLT2 inhibitors on glucose levels in patients with type 2 diabetes?

    <p>Inhibit glucose reabsorption from the glomerular filtrate, resulting in a reduced renal threshold for glucose and glycosuria</p> Signup and view all the answers

    What is the primary contra-indication for SGLT2 inhibitors in patients with type 2 diabetes?

    <p>Moderate to severe kidney impairment</p> Signup and view all the answers

    What is the primary nursing implication for patients taking antidiabetic medications and undergoing a test or procedure?

    <p>Consult the primary care provider to clarify orders for antidiabetic drug therapy</p> Signup and view all the answers

    What is the primary treatment for mild hypoglycemia in patients with type 2 diabetes?

    <p>Dietary changes to increase protein intake and lower carbohydrate intake</p> Signup and view all the answers

    What is the primary adverse effect of DPP-4 inhibitors that can occur when used in conjunction with a sulfonylurea?

    <p>Hypoglycemia</p> Signup and view all the answers

    What is the main disadvantage of delaying insulin administration until hyperglycemia occurs?

    <p>It results in large swings in glucose control.</p> Signup and view all the answers

    Which type of insulin is used as a basal insulin in Basal-Bolus Insulin Dosing?

    <p>Insulin glargine</p> Signup and view all the answers

    What is the first-line drug and most commonly used oral drug for the treatment of type 2 DM?

    <p>Metformin</p> Signup and view all the answers

    Which of the following is a common adverse effect of Sulfonylureas?

    <p>Hypoglycemia</p> Signup and view all the answers

    What is the mechanism of action of Thiazolidinediones?

    <p>Decrease insulin resistance</p> Signup and view all the answers

    Which of the following is a contraindication for Alpha-glucosidase inhibitors?

    <p>Certain bowel disorders</p> Signup and view all the answers

    What is the mechanism of action of Incretin mimetics?

    <p>Mimic naturally secreted incretin hormones</p> Signup and view all the answers

    What is the preferred method of treatment for hospitalized patients with DM?

    <p>Basal-Bolus Insulin Dosing</p> Signup and view all the answers

    Study Notes

    Diabetes Mellitus

    • Type 1 Diabetes Mellitus:
      • Lack of insulin production or production of defective insulin
      • Affected patients need exogenous insulin
      • Complications include diabetic ketoacidosis (DKA) and hyperosmolar hyperglycemic syndrome (HHS)
    • Type 2 Diabetes Mellitus:
      • Most common type (90% of all cases)
      • Caused by insulin deficiency and insulin resistance
      • Many tissues are resistant to insulin, including reduced number of insulin receptors and less responsive insulin receptors

    Signs and Symptoms of Diabetes

    • Elevated fasting blood glucose (higher than 126 mg/dL) or a hemoglobin A1C (HbA1C) level greater than or equal to 6.5%
    • Polyuria
    • Polydipsia
    • Polyphagia
    • Glycosuria
    • Unexplained weight loss
    • Fatigue
    • Blurred vision

    Type 2 Diabetes Mellitus Comorbid Conditions

    • Obesity
    • Coronary heart disease
    • Dyslipidemia
    • Hypertension
    • Microalbuminemia (protein in the urine)
    • Increased risk for thrombotic (blood clotting) events
    • These comorbidities are collectively referred to as metabolic syndrome, insulin-resistance syndrome, or syndrome X

    Major Long-Term Complications of Both Types of Diabetes

    • Macrovascular (atherosclerotic plaque):
      • Coronary arteries
      • Cerebral arteries
      • Peripheral vessels
    • Microvascular (capillary damage):
      • Retinopathy
      • Neuropathy
      • Nephropathy

    Gestational Diabetes

    • Hyperglycemia that develops during pregnancy
    • Insulin must be given to prevent birth defects
    • Usually subsides after delivery
    • 30% of patients may develop type 2 DM within 10 to 15 years

    Nonpharmacologic Treatment Interventions

    • Type 1: Always requires insulin therapy
    • Type 2:
      • Weight loss
      • Improved dietary habits
      • Smoking cessation
      • Reduced alcohol consumption
      • Regular physical exercise

    Glycemic Goal of Treatment

    • HbA1C of less than 7%
    • Fasting blood glucose goal for diabetic patients: 80 to 130 mg/dL

    Treatment Options for Diabetes

    • Type 1: Insulin therapy
    • Type 2:
      • Lifestyle changes
      • Oral drug therapy
      • Insulin when the above no longer provide glycemic control

    Insulin

    • Function as a substitute for the endogenous hormone
    • Effects are the same as normal endogenous insulin
    • Restores the diabetic patient's ability to:
      • Metabolize carbohydrates, fats, and proteins
      • Store glucose in the liver
      • Convert glycogen to fat stores

    Types of Insulin

    • Rapid-acting:
      • Onset of action: 5 to 15 minutes
      • Peak: 1 to 2 hours
      • Duration: 3 to 5 hours
      • Examples: insulin lispro (Humalog), insulin aspart (NovoLog), insulin glulisine (Apidra)
    • Short-acting:
      • Onset: 30 to 60 minutes
      • Peak: 2.5 hours
      • Duration: 6 to 10 hours
      • Examples: regular insulin (Humulin R)
    • Intermediate-acting:
      • Onset: 1 to 2 hours
      • Peak: 4 to 8 hours
      • Duration: 10 to 18 hours
      • Examples: insulin isophane suspension (NPH)
    • Long-acting:
      • Onset: 1 to 2 hours
      • Peak: none
      • Duration: 24 hours
      • Examples: insulin glargine (Lantus), insulin detemir (Levemir)

    Sliding Scale vs Bolus Insulin Dosing

    • Sliding-scale insulin dosing:
      • SUBQ rapid-acting or short-acting insulins are adjusted according to blood glucose test results
      • Typically used in hospitalized diabetic patients or those on total parenteral nutrition or enteral tube feedings
    • Basal-bolus insulin dosing:
      • Preferred method of treatment for hospitalized patients with DM
      • Mimics a healthy pancreas by delivering basal insulin constantly as a basal and then as needed as a bolus
      • Basal insulin is a long-acting insulin (insulin glargine), and bolus insulin is a rapid-acting insulin (insulin lispro or insulin aspart)

    Non-Insulin Antidiabetic Drugs

    • Biguanides:
      • Mechanism of action: decrease production of glucose by the liver, decrease intestinal absorption of glucose, and increase uptake of glucose by tissues
      • Adverse effects: primarily affects gastrointestinal (GI) tract, may also cause metallic taste, reduced vitamin B12 levels
      • Contraindications: renal or hepatic disease
      • Example: metformin (Glucophage)
    • Sulfonylureas:
      • Mechanism of action: stimulate insulin secretion from the beta cells of the pancreas, thus increasing insulin levels
      • Adverse effects: hypoglycemia, hematologic effects, nausea, epigastric fullness, heartburn
      • Contraindications: hypersensitivity to Sulphur, pregnancy
      • Examples: glimepiride (Amaryl), glipizide (Glucotrol), glyburide (DiaBeta)
    • Glinides:
      • Mechanism of action: similar to sulfonylureas, increase insulin secretion from the pancreas
      • Adverse effects: hypoglycemia, weight gain
      • Examples: repaglinide (Prandin), nateglinide (Starlix)
    • Thiazolidinediones (glitazones):
      • Mechanism of action: decrease insulin resistance, increase glucose uptake and use in skeletal muscle
      • Adverse effects: can cause or exacerbate heart failure, peripheral edema, weight gain, decreased bone marrow density
      • Contraindications: heart failure
      • Example: pioglitazone (Actos)
    • Alpha-glucosidase inhibitors:
      • Mechanism of action: decrease intestinal absorption of glucose
      • Adverse effects: flatulence, diarrhea, abdominal pain
      • Contraindications: certain bowel disorders
      • Examples: acarbose (Precose), miglitol (Glyset)
    • Incretin mimetics:
      • Mechanism of action: mimic naturally secreted incretin hormones, increase insulin synthesis and lower glucagon secretion
      • Adverse effects: upper respiratory tract infection, headache, diarrhea
      • Contraindications: pancreatitis
      • Examples: sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina)
    • SGLT2 inhibitors:
      • Mechanism of action: inhibit SGLT2, leading to a decrease in blood glucose caused by an increase in renal glucose excretion
      • Adverse effects: genital yeast infections, urinary tract infections, increased urination
      • Contraindications: diabetic ketoacidosis, moderate to severe kidney impairment
      • Examples: canagliflozin (Invokana), dapagliflozin (Farxiga), empagliflozin (Jardiance), ertugliflozin (Steglatro)

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    This quiz covers the differences between Type 1 and Type 2 Diabetes Mellitus, including symptoms and complications such as diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome.

    More Like This

    Use Quizgecko on...
    Browser
    Browser